Physician profile
Stephen W Dinger
NPI 1740227107
$19,185.33
in general payments reported to CMS, 2019-2025
29 companies · $3,718 in 2025
The $3,718 reported for 2025 was more than what 96% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,705 · 2020: $324 · 2021: $755 · 2022: $886 · 2023: $4,585 · 2024: $2,212 · 2025: $3,718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,444 · Travel and Lodging: $3,012 · Education: $58.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,444.10 |
| Travel and Lodging | $3,012.43 |
| Education | $58.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $5,379.91 | 2019-2020 | |
| Boston Scientific Corporation | $5,063.45 | 2019-2025 | General - Therapies, Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $2,499.27 | 2019-2024 | Senza |
| Relievant Medsystems, INC. | $1,083.22 | 2023 | Intracept |
| Globus Medical, INC. | $890.21 | 2025 | Senza, Vyrsa V1 |
| Si-Bone, INC. | $771.51 | 2019-2024 | |
| Abbott Laboratories | $557.75 | 2019-2025 | Proclaim, Eterna, Octrode |
| Spr Therapeutics, INC | $427.48 | 2022-2025 | Sprint Pns System |
| Painteq LLC | $365.89 | 2023-2024 | Painteq |
| Abbvie INC. | $301.02 | 2022-2025 | Botox, Qulipta |
| Mml US, INC. | $204.01 | 2024-2025 | Reactiv8 |
| Biotronik Nro, INC. | $195.96 | 2023-2024 | Prospera, Biotronik |
| Averitas Pharma INC. | $191.16 | 2024-2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $184.99 | 2023-2025 | Belbuca, Xtampza |
| Nalu Medical, INC. | $171.66 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $113.53 | 2023-2025 | Evoke, Evoke Scs |
| Almatica Pharma LLC | $112.96 | 2021 | |
| Medtronic, INC. | $104.54 | 2021-2024 | Intellis Adaptivestim |
| Avanos Medical | $104.12 | 2023-2025 | Generator |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.97 | 2019 | |
| Scilex Pharmaceuticals INC. | $95.46 | 2022-2024 | Ztlido |
| Aytu Biopharma, INC. | $70.13 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $50.33 | 2025 | |
| Ibsa Pharma INC. | $39.54 | 2023-2024 | Tirosint, Tirosint, Licart |
| Pacira Pharmaceuticals Incorporated | $36.14 | 2023 | Zilretta, Iovera |
| Glaxosmithkline, LLC. | $20.08 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $19.06 | 2023 | Ajovy |
| Grt US Holding, INC. | $16.52 | 2022 | |
| Depuy Synthes Sales INC. | $15.46 | 2025 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Dinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.